Stay updated on Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page’s revision/build indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.1%
    Check dated 2026-04-23T21:53:19.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Footer revision label updated from Revision: v3.5.0 to Revision: v3.5.2. This indicates a minor site maintenance update with no changes to study content or data visible on the page.
    Difference
    0.1%
    Check dated 2026-04-16T12:37:47.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    48 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added. Revision: v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T21:16:48.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:05:23.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added, and the previous funding/operating-status notice has been removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:16:08.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Added a site-wide notice about a lapse in government funding and NIH Clinical Center operations, and updated the page revision to v3.4.1 (replacing v3.4.0).
    Difference
    0.4%
    Check dated 2026-02-04T00:24:19.000Z thumbnail image

Stay in the know with updates to Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Erlotinib in Pancreatic Cancer Clinical Trial page.